BLNK is an adaptor protein of the B-cell receptor signaling pathway and has been identified as an independent risk factor for colorectal cancer recurrence as well as a positive regulator of Met signaling in non-small cell lung cancer [66, 67]. Here, MET is linked to colorectal cancer.